Small Molecules
8 November 2017
New Preclinical Research Suggests Utility of Tetra Discovery Partners’ BPN14770 to Provide Therapeutic Benefit in Fragile X Syndrome7 November 2017
Esperion Announces Initiation of Pivotal Phase 3 Study for the Bempedoic Acid / Ezetimibe Combination Pill7 November 2017
FDA Approves Genentech’s Alecensa (Alectinib) as First-Line Treatment for People with Specific Type of Lung Cancer7 November 2017
FDA Approves Zelboraf (Vemurafenib) for Erdheim-Chester Disease with BRAF V600 Mutation6 November 2017
Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in ALS6 November 2017
Tyme Announces Encouraging Efficacy and Safety Data from First Human Study of SM-88 in Women with Metastatic Breast Cancer4 November 2017
Otsuka Announces Phase 3 Results for Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)3 November 2017
Bausch + Lomb And Nicox Announce FDA Approval Of VYZULTA™ (latanoprostene Bunod Ophthalmic Solution), 0.024%2 November 2017
Trevena Announces Submission of New Drug Application to U.S. FDA for OLINVO™ (oliceridine injection)2 November 2017
Synspira Announces Data for Lead Candidate at the 31st Annual North American Cystic Fibrosis ConferenceNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports